Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts-Reference-Cited by-同舟云学术

Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts

Published:2016-09-19 Issue:1 Volume:140 Page:197-207
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vázquez Ramiro¹,Licandro Simonetta Andrea¹,Astorgues-Xerri Lucile²,Lettera Emanuele¹,Panini Nicolò¹,Romano Michela¹,Erba Eugenio¹,Ubezio Paolo¹,Bello Ezia¹,Libener Roberta³,Orecchia Sara³,Grosso Federica³,Riveiro María Eugenia²,Cvitkovic Esteban²⁴,Bekradda Mohamed²,D'Incalci Maurizio¹,Frapolli Roberta¹

Affiliation:

1. Laboratory of Cancer Pharmacology; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri; Milan Italy

2. Oncology Therapeutic Development; Clichy France

3. Cytogenetic and Molecular Pathology Laboratory, Pathology Unit, Oncology; SS Antonio e Biagio e Cesare Arrigo General Hospital; Alessandria Italy

4. Oncoethix SA (now Oncoethix GmbH, a wholly owned subsidiary of Merck Sharp & Dohme Corp); Lucerne Switzerland

Funder

Fondazione Buzzi Unicem Onlus

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Malignant mesothelioma;Ahmed;Pak J Med Sci,2013

2. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group;Husain;Arch Pathol Lab Med,2009

3. Malignant pleural mesothelioma;Ceresoli;Ann Oncol,2006

4. Pleural mesothelioma: little evidence, still time to do trials;Treasure;Lancet,2004

5. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma;Scherpereel;Eur Respir J,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC the oncogene from hell: Novel opportunities for cancer therapy;European Journal of Medicinal Chemistry;2024-03

2. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products;Aging and disease;2024

3. OTX015 PROTACs: Emerging Novel Therapeutic Agents in Cancer Treatment;BIO Web of Conferences;2024

4. MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments;Briefings in Bioinformatics;2023-11-22

5. Laser ablation‐inductively coupled plasma‐mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma;British Journal of Clinical Pharmacology;2023-07-14